Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness
Sponsor
Innovative Medical (Industry)
Overall Status
Completed
CT.gov ID
NCT00469521
Collaborator
(none)
1
Study Details
Study Description
Brief Summary
To determine baseline tear thickness and improvement immediately post installation of two artificial tear solutions:(9582X) and Allergan Refresh Tears.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Phase 4 |
Study Design
Study Type:
Interventional
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
-
Normal, healthy volunteers 18 years or older
-
Males or females
-
Any race or ethnic background
Exclusion Criteria:
-
Corneal refractive surgery within 6 months of this study.
-
Contact lens use on day of examination.
-
Corneal ectasia
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Magill Research Center Institute MUSC | Charleston | South Carolina | United States | 29425 |
Sponsors and Collaborators
- Innovative Medical
Investigators
- Principal Investigator: Helga Sandoval, MS, MD, Magill Research Center Institute MUSC
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00469521
Other Study ID Numbers:
- 5304
First Posted:
May 4, 2007
Last Update Posted:
Sep 10, 2007
Last Verified:
Sep 1, 2007